Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,497

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,881

Class I recallsReasonable probability of serious health consequences

24,543

Class II recallsTemporary or medically reversible health consequences

2,935

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,098 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-all-cheddar-cheese-products-because-possible-health-riskPublished November 10, 2026

Most affected stateHawaii 200 recalls mention this state

Advertisement

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 12, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

FDA Recall OngoingHistorical recordClass II

Methylcobalamin 25 mg/ml Inj and 5000 mcg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Methylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Metabolase Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Metabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Medroxyprogesterone 150 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Medetomidine 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Lipotoxin Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Ketamine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

ITPP 50 mg/ml DMG 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Iodine 20 mg Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Idoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Hippiron 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

HCG 125iu/0.25ml (550iu/ml), 3500iu and 10,000iu, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

HACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Guanabenz 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Guanabenz 8 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Glutathione 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Gentamicin Sulfate 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Gentamicin 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Published: July 17, 2013
Distribution: Nationwide

View recall →

Data last updated: November 12, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.